Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
10.03
-0.32 (-3.09%)
Jan 29, 2026, 12:33 PM EST - Market open
Neogen Market Cap
Neogen has a market cap or net worth of $2.18 billion as of January 29, 2026. Its market cap has decreased by -18.54% in one year.
Market Cap
2.18B
Enterprise Value
2.90B
1-Year Change
-18.54%
Ranking
Category
Stock Price
$10.03
Market Cap Chart
Since December 1, 1998, Neogen's market cap has increased from $43.50M to $2.18B, an increase of 4,915.60%. That is a compound annual growth rate of 15.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 2.23B | 46.79% |
| Dec 31, 2025 | 1.52B | -42.26% |
| Dec 31, 2024 | 2.63B | -39.52% |
| Dec 29, 2023 | 4.35B | 164.86% |
| Dec 30, 2022 | 1.64B | -66.44% |
| Dec 31, 2021 | 4.89B | 15.90% |
| Dec 31, 2020 | 4.22B | 22.74% |
| Dec 31, 2019 | 3.44B | 15.87% |
| Dec 31, 2018 | 2.97B | -5.55% |
| Dec 29, 2017 | 3.14B | 25.42% |
| Dec 30, 2016 | 2.51B | 18.64% |
| Dec 31, 2015 | 2.11B | 15.26% |
| Dec 31, 2014 | 1.83B | 10.30% |
| Dec 31, 2013 | 1.66B | 53.65% |
| Dec 31, 2012 | 1.08B | 50.01% |
| Dec 30, 2011 | 720.90M | -22.72% |
| Dec 31, 2010 | 932.80M | 77.47% |
| Dec 31, 2009 | 525.60M | 44.32% |
| Dec 31, 2008 | 364.20M | -3.50% |
| Dec 31, 2007 | 377.40M | 84.73% |
| Dec 29, 2006 | 204.30M | 18.37% |
| Dec 30, 2005 | 172.60M | -5.84% |
| Dec 31, 2004 | 183.30M | 17.80% |
| Dec 31, 2003 | 155.60M | 70.05% |
| Dec 31, 2002 | 91.50M | -14.49% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sotera Health Company | 5.28B |
| GRAIL | 4.14B |
| BillionToOne | 3.94B |
| Veracyte | 3.21B |
| GeneDx Holdings | 3.03B |
| Twist Bioscience | 2.60B |
| NeoGenomics | 1.61B |
| Castle Biosciences | 1.26B |